(NASDAQ: ZLAB) Zai Lab's forecast annual revenue growth rate of 31.37% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 101.28%, and while it is forecast to beat the US market's average forecast revenue growth rate of 25.61%.
Zai Lab's revenue in 2025 is $441,629,000.On average, 11 Wall Street analysts forecast ZLAB's revenue for 2025 to be $574,523,523,824, with the lowest ZLAB revenue forecast at $498,556,670,080, and the highest ZLAB revenue forecast at $656,727,865,632. On average, 11 Wall Street analysts forecast ZLAB's revenue for 2026 to be $773,924,073,104, with the lowest ZLAB revenue forecast at $627,132,975,456, and the highest ZLAB revenue forecast at $927,439,271,360.
In 2027, ZLAB is forecast to generate $1,140,221,665,600 in revenue, with the lowest revenue forecast at $847,126,082,848 and the highest revenue forecast at $1,441,036,692,800.